Pietro Lapidari (@plapidari) 's Twitter Profile
Pietro Lapidari

@plapidari

Medical Oncologist at
@GustaveRoussy, PhD Student

ID: 1306521642131173378

calendar_today17-09-2020 09:13:41

5 Tweet

49 Takipçi

56 Takip Edilen

Antonio Di Meglio, MD, PhD (@dimeglio_anto) 's Twitter Profile Photo
Antonio Di Meglio, MD, PhD
@dimeglio_anto

5 years ago

Our CANTO analysis on the impact of G-CSF 💉 on long-term PROs 📝👩‍💻 and hematological toxicity 🔬in women with early breast cancer @ #ESMO20 / mini-oral session 🖥️. Great job Pietro Lapidari 👨‍🔬🥼! Abstract 1817MO 📄 Ines Vaz Luis, MD Gustave Roussy FabriceAndre @GroupeUNICANCER

Our CANTO analysis on the impact of G-CSF 💉 on long-term PROs 📝👩‍💻 and hematological toxicity 🔬in women with early breast cancer @ #ESMO20 / mini-oral session 🖥️. Great job <a href="/PLapidari/">Pietro Lapidari</a> 👨‍🔬🥼! Abstract 1817MO 📄 <a href="/inesvazluis/">Ines Vaz Luis, MD</a> <a href="/GustaveRoussy/">Gustave Roussy</a> <a href="/FAndreMD/">FabriceAndre</a> @GroupeUNICANCER
Pietro Lapidari (@plapidari) 's Twitter Profile Photo
Pietro Lapidari
@plapidari

2 years ago

I’m honored to be a part of this and a 2023 #ConquerCancer award recipient. The donors that make these grants possible also make #cancerbreakthroughs happen. Help support #ConquerCancer and the next generation of researchers: fal.cn/3yzGu #WeConquerCancer #ASCO23

Pietro Lapidari (@plapidari) 's Twitter Profile Photo
Pietro Lapidari
@plapidari

a year ago

Well deserved Ines Vaz Luis ! A huge privilege to be mentored by you!

Gustave Roussy (@gustaveroussy) 's Twitter Profile Photo
Gustave Roussy
@gustaveroussy

a year ago

Benjamin Besse d.planchard Fabrice Barlesi ESMO - Eur. Oncology Pierre Blanchard, MD Ines Vaz Luis 🔹 Dr Pietro Lapidari presenting the development and validation of a predictive model of aromatase inhibitor musculoskeletal toxicity among patients with early-stage breast cancer at ESMO - Eur. Oncology.

<a href="/BenjaminBesseMD/">Benjamin Besse</a> <a href="/dplanchard/">d.planchard</a> <a href="/barlesi/">Fabrice Barlesi</a> <a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/PBlanchardMD/">Pierre Blanchard, MD</a> <a href="/ines_vazluis/">Ines Vaz Luis</a> 🔹 Dr Pietro Lapidari presenting the development and validation of a predictive model of aromatase inhibitor musculoskeletal toxicity among patients with early-stage breast cancer at <a href="/myESMO/">ESMO - Eur. Oncology</a>.